Cannabis use appears to increase risk of type 2 diabetes
A large retrospective study suggests that cannabis use could quadruple the risk of developing type 2 diabetes. The findings were presented on Sept. 15, 2025 at the Annual… read more.
A large retrospective study suggests that cannabis use could quadruple the risk of developing type 2 diabetes. The findings were presented on Sept. 15, 2025 at the Annual… read more.
Researchers report that patients with psoriasis treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) have achieved a 78% reduced risk of death and a 44% reduced risk of major… read more.
Patients with both T2D (type 2 diabetes) and OSA (obstructive sleep apnea) who were treated with CPAP (continuous positive airway pressure) achieved an approximately 26% lower risk of… read more.
Researchers report that few people in the USA use salt substitutes to help control high blood pressure despite the fact they are a simple and effective method to… read more.
Over an 18-month period, patients suffering with insomnia who were treated with cannabis- based medical products reported improvement in sleep. The findings were published on Aug. 27, 2025… read more.
Investigators report that two out of three women of reproductive age in the USA have at least one modifiable risk factor for birth defects. The findings were published… read more.
Researchers report that spironolactone, a medication for high blood pressure and heart failure, does not reduce the risk of heart-related death or hospitalization among patients with kidney failure… read more.
Researchers report that treating complicated Staphylococcus aureus bloodstream infections with two intravenous (IV) doses of the antibiotic dalbavancin seven days apart is as effective as treatment with daily… read more.
Use of the diabetes drug metformin appears to be linked to reduced risk of dementia and death in obese patients, researchers reported on August 6, 2025 in Diabetes,… read more.
Low-dose (5mg) olanzapine reduces chemo-induced nausea in breast cancer patients without causing sedation, researchers reported on July 1, 2025 in The Lancet Oncology. As background for this study,… read more.
Researchers report that treatment of type 2 diabetes with glucagon- like peptide- 1 receptor agonists (GLP- 1 RAs) more effectively reduces the subsequent risk of dementia than treatment… read more.
Findings from a randomized controlled trial suggest that vaporized nicotine products (vapes) are more effective than nicotine replacement therapies for smoking cessation in a low socioeconomic status population…. read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.